A whopping 135 batches of blood stress medicine have been recalled over fears that the capsule capsules will not correctly dissolve when ingested by sufferers.Glenmark Prescription drugs initiated a voluntary recall of 114 batches of 750 mg Potassium Chloride in bottles containing 100 and 500 tablets, with all the particular batch numbers and expiration dates listed in a doc circulated by the FDA. Likewise, American Well being Packaging voluntarily recalled 21 batches of the identical drugs on behalf of BluePoint Laboratories. In response to an organization announcement, the failed dissolution of the potassium chloride prolonged launch capsules may trigger excessive potassium ranges within the blood, often known as hyperkalemia.Hyperkalemia could cause an ‘irregular coronary heart beat that may result in cardiac arrest.’ Glenmark Prescription drugs just lately initiated a voluntary recall of 114 batches of 750 mg Potassium Chloride in bottles containing 100 and 500 tablets Pictured: The defective capsule capsules which were recalled by Glenmark Prescription drugs and American Well being Packaging Pictured: The label discovered on the 500-capsule bottle of the recalled blood stress drugs Pictured: The label discovered on the 500-capsule bottle of the recalled blood stress drugs carrying the BluePoint Laboratories model title Sufferers who take this drugs to handle hypertension and stop coronary heart or kidney failure are at excessive threat, for the reason that bodily supply of the tablets have been compromised.People who’re prescribed these specific recalled batches may expertise a spread of hyperkalemia signs, together with ‘cardiac arrhythmias, extreme muscle weak spot, and demise.’Glenmark hasn’t but acquired reviews of hyperkalemia or any of the described antagonistic occasions. These potassium chloride tablets have already been distributed to wholesale, distributor and stores all throughout the nation, main Glenmark to put in writing these prospects letters telling them to instantly take the merchandise of the cabinets.Individuals who have been prescribed this drugs are being instructed to seek the advice of with their physician earlier than they cease taking it.Moreover, the corporate recommends customers name their physician or healthcare supplier in the event that they expertise the beginnings of any hyperkalemia signs.The FDA is urging individuals to report antagonistic occasions to its MedWatch Adversarial Occasion Reporting program both on-line, by common mail or by fax.